Anaplastic Thyroid Cancer Drugs - Global Market Outlook (2017-2026)

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Anaplastic Thyroid Cancer Drugs Market, By Type
5.1 Introduction
5.2 Crolibulin
5.3 Efatutazone
5.4 GLONC-2
5.5 CLM-94
5.6 Other Types

6 Global Anaplastic Thyroid Cancer Drugs Market, By Product
6.1 Introduction
6.2 Sorafenib (phase 2)
6.3 Paclitaxel and Pazopanib HCl (phase 2)
6.4 MLN0128 (phase 2)
6.5 Lapatinib Ditosylate and Dabrafenib (phase 1)
6.6 Everolimus (phase 2)
6.7 CS7017 (phase 1)
6.8 Crolibulin (phase 1)
6.9 Cabozantinib (phase 2)
6.10 CA4P (phase 2)
6.11 Bevacizumab (phase 2)
6.12 Other Products

7 Global Anaplastic Thyroid Cancer Drugs Market, By Treatments
7.1 Introduction
7.2 Surgical Treatments
7.3 Radiation Therapy
7.4 Novel Therapy
7.5 Cryosurgery
7.6 Chemotherapy

8 Global Anaplastic Thyroid Cancer Drugs Market, By Method
8.1 Introduction
8.2 Oral
8.3 Injection

9 Global Anaplastic Thyroid Cancer Drugs Market, By Application
9.1 Introduction
9.2 Clinic
9.3 Hospital
9.4 Other Applications

10 Global Anaplastic Thyroid Cancer Drugs Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.6 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Pfizer Inc.
12.2 Daiichi Sankyo Company, Limited
12.3 Trophogen, Inc.
12.4 Plexxikon Inc.
12.5 Novartis AG
12.6 Millennium Pharmaceuticals Inc
12.7 Immune Pharmaceuticals Inc.
12.8 Genelux Corporation

List of Tables
Table 1 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Region (2016-2026) (US $MN)
Table 2 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Type (2016-2026) (US $MN)
Table 3 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Crolibulin (2016-2026) (US $MN)
Table 4 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Efatutazone (2016-2026) (US $MN)
Table 5 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By GLONC-2 (2016-2026) (US $MN)
Table 6 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By CLM-94 (2016-2026) (US $MN)
Table 7 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Other Types (2016-2026) (US $MN)
Table 8 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Product (2016-2026) (US $MN)
Table 9 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Sorafenib (phase 2) (2016-2026) (US $MN)
Table 10 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Paclitaxel and Pazopanib HCl (phase 2) (2016-2026) (US $MN)
Table 11 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By MLN0128 (phase 2) (2016-2026) (US $MN)
Table 12 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Lapatinib Ditosylate and Dabrafenib (phase 1) (2016-2026) (US $MN)
Table 13 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Everolimus (phase 2) (2016-2026) (US $MN)
Table 14 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By CS7017 (phase 1) (2016-2026) (US $MN)
Table 15 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Crolibulin (phase 1) (2016-2026) (US $MN)
Table 16 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Cabozantinib (phase 2) (2016-2026) (US $MN)
Table17 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By CA4P (phase 2) (2016-2026) (US $MN)
Table 18 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Bevacizumab (phase 2) (2016-2026) (US $MN)
Table 19 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Other Products (2016-2026) (US $MN)
Table 20 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Treatments (2016-2026) (US $MN)
Table 21 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Surgical Treatments (2016-2026) (US $MN)
Table 22 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
Table 23 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Novel Therapy (2016-2026) (US $MN)
Table 24 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Cryosurgery (2016-2026) (US $MN)
Table 25 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Chemotherapy (2016-2026) (US $MN)
Table 26 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Method (2016-2026) (US $MN)
Table 27 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Oral (2016-2026) (US $MN)
Table 28 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Injection (2016-2026) (US $MN)
Table 29 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Application (2016-2026) (US $MN)
Table 30 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Clinic (2016-2026) (US $MN)
Table 31 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Hospital (2016-2026) (US $MN)
Table 32 Global Anaplastic Thyroid Cancer Drugs Market Outlook, By Other Applications (2016-2026) (US $MN)


NOTE: Tables for North America, Europe, Asia Pacific, South America, and Middle East & Africa are represented in the same manner above.

Report Details

  • Report Code:12208
  • Category:Healthcare
  • No. of Pages:164
  • Format:PDF/PPT/Excel
  • Published:August 2019
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers